Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 41.80 INR
Change Today +0.20 / 0.48%
Volume 85.2K
BRD On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:15 AM 05/25/15 All times are local (Market data is delayed by at least 15 minutes).

beryl drugs ltd (BRD) Snapshot

Open
42.00
Previous Close
41.60
Day High
42.50
Day Low
41.05
52 Week High
05/5/15 - 49.80
52 Week Low
07/14/14 - 20.65
Market Cap
212.0M
Average Volume 10 Days
63.3K
EPS TTM
0.57
Shares Outstanding
5.1M
EX-Date
--
P/E TM
73.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for BERYL DRUGS LTD (BRD)

Related News

No related news articles were found.

beryl drugs ltd (BRD) Related Businessweek News

No Related Businessweek News Found

beryl drugs ltd (BRD) Details

Beryl Drugs Ltd. manufactures and markets generic pharmaceutical formulations in India. The company offers small volume injectables in liquid and dry powder form, eye and ear drops, I.V. fluids in polypack and glass bottles, and veterinary medicines. It also provides research and development, and contract manufacturing services. Beryl Drugs Ltd. was founded in 1993 and is based in Indore, India.

Founded in 1993

beryl drugs ltd (BRD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

beryl drugs ltd (BRD) Key Developments

Beryl Drugs Ltd. Reports Un-Audited Earnings Results for the Fourth Quarter and Year Ended March 31, 2015

Beryl Drugs Ltd. reported un-audited earnings results for the fourth quarter and year ended March 31, 2015. For the quarter, the company reported income form services of INR 37,921,000 compared to INR 28,017,000, loss from operations before other income, interest & tax of INR 414,000 compared to INR 1,535,000, profit before tax INR 320,000 compared to loss before income tax INR 474,000 and net profit of INR 20,000 or INR 0.00 per basic and diluted share compared to net loss of INR 875,000 or INR 0.17 per basic and diluted share for the last year. For the year, the company reported income form services of INR 136,250,000 compared to INR 148,145,000, profit from operations before other income, interest & tax of INR 4,540,000 compared to INR 4,306,000, profit before tax INR 3,990,000 compared to INR 4,290,000 and net profit of INR 2,890,000 or INR 0.57 per basic and diluted share compared to net loss of INR 2,990,000 or INR 0.59 per basic and diluted share for the last year.

Beryl Drugs Ltd. to Report Q4, 2015 Results on Apr 20, 2015

Beryl Drugs Ltd. announced that they will report Q4, 2015 results on Apr 20, 2015

Beryl Drugs Ltd., Board Meeting, Apr 20, 2015

Beryl Drugs Ltd., Board Meeting, Apr 20, 2015. Agenda: To consider unaudited financial results for the quarter ended on March 31, 2015; and to take note of general disclosures of interest of directors under section 184(1) in form MBP-1.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRD:IN 41.80 INR +0.20

BRD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BRD.
View Industry Companies
 

Industry Analysis

BRD

Industry Average

Valuation BRD Industry Range
Price/Earnings 72.1x
Price/Sales 1.6x
Price/Book -- Not Meaningful
Price/Cash Flow 37.1x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BERYL DRUGS LTD, please visit www.beryldrugs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.